Showing 1 - 5 results of 5 for search 'Ruiling Ning', query time: 0.03s Refine Results
  1. 1
    Pretreatment plasma -dimer levels as an independent prognostic factor for overall survival among patients with advanced non-small-cell lung cancer

    Pretreatment plasma -dimer levels as an independent prognostic factor for overall survival among patients with advanced non-small-cell lung cancer by Qianfei Liu, Jianbo He, Ruiling Ning, Liping Tan, Aiping Zeng, Shaozhang Zhou

    Published 2020-10-01
    Get full text
    Article
  2. 2
    The Effect of Aging on the Molecular Distribution of Crumb Rubber Modified Asphalt Based on the Gel Permeation Chromatography Test

    The Effect of Aging on the Molecular Distribution of Crumb Rubber Modified Asphalt Based on the Gel Permeation Chromatography Test by Tao Wang, Zixuan Chen, Yi Wang, Yaping Cui, Yunhong Sun, Ruiling Ning, Yu Tian, Yi Zhang

    Published 2023-04-01
    Get full text
    Article
  3. 3
    NSCLC patients with rare EGFR Ex19del/G724S mutation showed good response to afatinib combined with chemotherapy treatment: A two-case report

    NSCLC patients with rare EGFR Ex19del/G724S mutation showed good response to afatinib combined with chemotherapy treatment: A two-case report by Huilin Wang, Qitao Yu, Lina Shi, Qinhan Hou, Liang Dan, Chuqiao Liang, Xiaoyu Hong, Yun Zhao, Ruiling Ning

    Published 2022-11-01
    Get full text
    Article
  4. 4
    Case Report: The effective treatment of patients in advanced no-small cell lung cancer patients with EGFR G719X/S768I/L861Q and acquired MET amplification: A case series and literature review

    Case Report: The effective treatment of patients in advanced no-small cell lung cancer patients with EGFR G719X/S768I/L861Q and acquired MET amplification: A case series and litera... by Yun Zhao, Cuiyun Su, Lina Shi, Wenqi Luo, Zhen Liu, Chuqiao Liang, Huilin Wang, Ruiling Ning, Qitao Yu, Wei Jiang

    Published 2023-02-01
    Get full text
    Article
  5. 5
    PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with advanced non-small cell lung cancer: A real-world retrospective cohort study

    PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with ad... by Shubin Chen, Haowen Wei, Wenhua Zhao, Wei Jiang, Ruiling Ning, Shaozhang Zhou, Liping Tan, Huilin Wang, Cuiyun Su, Jianbo He, Aiping Zeng, Yun Zhao, Yun Zhao, Qitao Yu

    Published 2022-12-01
    Get full text
    Article

Search Tools: